April 22nd 2024
The vaccine’s developer, YS Biopharma, will begin its phase 1 clinical trial in the Philippines this summer.
CDC ACIP Votes to Recommend an Additional Dose of COVID-19 Vaccine in Seniors
February 28th 2024With today's vote, the federal agency’s Advisory Committee on Immunization Practices (ACIP) is now recommending people 65 years of age and older get 1 more dose of the 2023-2024 formula of the COVID-19 vaccine.
Read More
Email Reminders for Influenza Vaccine Uptake May Be Less Effective in Patients with Diabetes
December 21st 2023Analysis of the NUDGE-FLU study reveals electronic nudges designed to boost influenza vaccination were more effective in older adults without diabetes, highlighting the need for tailored approaches in diabetes populations.
Read More